Pain Alleviation and Opioid Weaning in an 80-Year-Old with Chronic Foot Pain Following Injection Therapy with Perineural Dexmedetomidine and Dexamethasone.
Amnon A BergerIvan UritsJamal HasoonAlan D KayeOmar ViswanathJonathan EskanderPublished in: Surgery journal (New York, N.Y.) (2021)
Opiates are routinely used for chronic pain patients, and up to 44% of them will have a prescription for an opiate medication for pain alleviation. However, of the 76 million adults prescribed opiates for pain management, about 12% report misuse, and a large number of these may find themselves addicted to opioid medications. Opioid addiction is an ongoing epidemic, costing many lives. Withdrawal is very difficult. This requires providers to consider alternative analgesic plans and minimize opiate use. Here we report the use of a dexamethasone-dexmedetomidine combination for a regional nerve block in an elderly woman chronically treated with opiate medications who had previously failed opiate weaning. Following her nerve block, she was able to completely wean off of opioids and continues having good pain control with an opioid-free regimen.
Keyphrases
- chronic pain
- pain management
- end stage renal disease
- newly diagnosed
- high dose
- low dose
- ejection fraction
- chronic kidney disease
- stem cells
- prognostic factors
- patient reported outcomes
- intensive care unit
- ultrasound guided
- bone marrow
- spinal cord injury
- acute respiratory distress syndrome
- electronic health record
- extracorporeal membrane oxygenation
- cell therapy